Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

9.0%

6 terminated/withdrawn out of 67 trials

Success Rate

90.8%

+4.3% vs industry average

Late-Stage Pipeline

76%

51 trials in Phase 3/4

Results Transparency

47%

28 of 59 completed trials have results

Key Signals

1 recruiting28 with results

Enrollment Performance

Analytics

Phase 3

28(43.8%)

Phase 4

23(35.9%)

Phase 2

6(9.4%)

Phase 1

5(7.8%)

N/A

2(3.1%)

64Total

Phase 3(28)

Phase 4(23)

Phase 2(6)

Phase 1(5)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (67)

Showing 20 of 67 trials

NCT05190744Phase 2Completed

Probenecid (PB) to Treat Hereditary Nephrogenic Diabetes Insipidus (NDI), ADPKD Treated With Tolvaptan, and Severely Polyuric Patients With Previous Lithium Administration

Role: collaborator

NCT01246765Recruiting

National Pregnancy Registry for Psychiatric Medications

Role: collaborator

NCT03063944Phase 1Completed

STAT Inhibitor OPB-111077, Decitabine and Venetoclax in Treating Patients With Acute Myeloid Leukemia That Is Refractory, Relapsed or Newly Diagnosed and Ineligible for Intensive Chemotherapy

Role: collaborator

NCT02237417Phase 4Completed

Impact of Aripiprazole Once Monthly Medications on Changes in Brain Structure and Metabolism

Role: collaborator

NCT01182415Phase 2Completed

High Dose Chemotherapy and Stem Cell Transplant for Non-Hodgkin's Lymphoma or Central Nervous System (CNS) Lymphoma

Role: collaborator

NCT02476409Phase 4Completed

Tolvaptan For Worsening Outpatient Heart Failure: Role of Copeptin In Identifying Responders

Role: collaborator

NCT03418675Phase 2Completed

Brexpiprazole in Borderline Personality Disorder

Role: collaborator

NCT01131169Phase 2Completed

Busulfan, Melphalan, Fludarabine and T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Followed by Post Transplantation Donor Lymphocyte Infusions

Role: collaborator

NCT02360319Phase 4Completed

Comparison of a Long-acting Injectable Antipsychotic vs Clinician's Choice Early in Treatment to Break the Cycle of Relapse in Early Phase Schizophrenics

Role: collaborator

NCT02538016Not ApplicableCompleted

TCUPS- Tolvaptan Use in Cystinuria and Urolithiasis: A Pilot Study

Role: collaborator

NCT02183792Phase 4Completed

Aquaresis Utility for Hyponatremic Acute Heart Failure Study

Role: collaborator

NCT02472652Phase 4Terminated

Aripiprazole, Abilify Maintena Collaborative Clinical Protocol

Role: collaborator

NCT03427892Phase 4Completed

Brexpiprazole for Bipolar Depression